Verrica Pharmaceuticals Inc. (VRCA) › Shareholders' EquityVerrica Pharmaceuticals Inc. (VRCA) — Shareholders' EquityAnnual figures by fiscal year, from SEC filings.2016: -$2.66M2017: -$7.04M2018: $89.43M2019: $65.02M2020: $32.99M2021: $32.60M2022: $40.03M2023: $19.76M2024: -$9.86M2025: $24.74M$24.74M2016Shareholders' Equity (USD)2025Fiscal YearShareholders' EquityChange YoY2025$24.74M+350.9%2024-$9.86M-149.9%2023$19.76M-50.6%2022$40.03M+22.8%2021$32.60M-1.2%2020$32.99M-49.3%2019$65.02M-27.3%2018$89.43M+1370.1%2017-$7.04M-164.3%2016-$2.66M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share